Literature DB >> 33127501

Respiratory pathogen diversity and co-infections in rural Zambia.

Gideon Loevinsohn1, Justin Hardick2, Pamela Sinywimaanzi3, Katherine Z J Fenstermacher4, Kathryn Shaw-Saliba4, Mwaka Monze5, Charlotte A Gaydos2, Richard E Rothman4, Andrew Pekosz6, Philip E Thuma7, Catherine G Sutcliffe8.   

Abstract

OBJECTIVES: The role of respiratory co-infections in modulating disease severity remains understudied in southern Africa, particularly in rural areas. This study was performed to characterize the spectrum of respiratory pathogens in rural southern Zambia and the prognostic impact of co-infections.
METHODS: Respiratory specimens collected from inpatient and outpatient participants in a viral surveillance program in 2018-2019 were tested for selected viruses and atypical bacteria using the Xpert Xpress Flu/RSV assay and FilmArray Respiratory Panel EZ. Participants were followed for 3-5 weeks to assess their clinical course. Multivariable regression was used to examine the role of co-infections in influencing disease severity.
RESULTS: A respiratory pathogen was detected in 63.2% of samples from 671 participants who presented with influenza-like illness. Common pathogens identified included influenza virus (18.2% of samples), respiratory syncytial virus (RSV) (11.8%), rhinovirus (26.4%), and coronavirus (6.0%). Overall, 6.4% of participants were co-infected with multiple respiratory pathogens. Compared to mono-infections, co-infections were found not to be associated with severe clinical illness either overall (relative risk (RR) 0.72, 95% confidence interval (CI) 0.39-1.32) or specifically with influenza virus (RR 0.80, 95% CI 0.14-4.46) or RSV infections (RR 0.44, 95% CI 0.17-1.11).
CONCLUSIONS: Respiratory infections in rural southern Zambia were associated with a wide range of viruses. Respiratory co-infections in this population were not associated with clinical severity.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Co-infections; Respiratory viruses; Rural; Severity; Sub-Saharan

Year:  2020        PMID: 33127501     DOI: 10.1016/j.ijid.2020.10.054

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

1.  Epidemiology and clinical features of common community human coronavirus disease.

Authors:  Taehee Kim; Hayoung Choi; Tae Rim Shin; Yousang Ko; Yong Bum Park; Hwan Il Kim; Seung Hun Jang; Ki Suck Jung; Youlim Kim; Myung Goo Lee; Soojie Chung; Cheol-Hong Kim; In Gyu Hyun; Yun Su Sim
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

Review 2.  The Complexity of Co-Infections in the Era of COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-04-23

3.  Attenuated infection by a Pteropine orthoreovirus isolated from an Egyptian fruit bat in Zambia.

Authors:  Hayato Harima; Michihito Sasaki; Yasuko Orba; Kosuke Okuya; Yongjin Qiu; Christida E Wastika; Katendi Changula; Masahiro Kajihara; Edgar Simulundu; Tomoyuki Yamaguchi; Yoshiki Eto; Akina Mori-Kajihara; Akihiko Sato; Satoshi Taniguchi; Ayato Takada; Masayuki Saijo; Bernard M Hang'ombe; Hirofumi Sawa
Journal:  PLoS Negl Trop Dis       Date:  2021-09-07

4.  Viral co-infections are associated with increased rates of hospitalization in those with influenza.

Authors:  Kerry L Shannon; Valerie O Osula; Kathryn Shaw-Saliba; Justin Hardick; Breana McBryde; Andrea Dugas; Yu-Hsiang Hsieh; Bhakti Hansoti; Richard E Rothman
Journal:  Influenza Other Respir Viruses       Date:  2022-03-18       Impact factor: 5.606

5.  Respiratory viruses in rural Zambia before and during the COVID-19 pandemic.

Authors:  Gideon Loevinsohn; Mutinta Hamahuwa; Justin Hardick; Pamela Sinywimaanzi; Katherine Z J Fenstermacher; Passwell Munachoonga; Austin Weynand; Mwaka Monze; Yukari C Manabe; Charlotte A Gaydos; Richard E Rothman; Andrew Pekosz; Philip E Thuma; Edgar Simulundu; Catherine G Sutcliffe
Journal:  Trop Med Int Health       Date:  2022-06-08       Impact factor: 3.918

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.